Citizens JMP downgraded Ibotta (IBTA) to Market Perform from Outperform without a price target following the Q2 report. The firm says the company’s product investments are taking more time than expected as it restructures its sales force. Citizens materially lowered 2026 revenue and EBITDA estimates and believes Ibotta has limited revenue visibility in the near term.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBTA: